{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["41(4)"],"submitter":["Diana P"],"pubmed_abstract":["<h4>Purpose</h4>To systematically review studies focused on screening programs for renal cell carcinoma (RCC) and provide an exhaustive overview on their clinical impact, potential benefits, and harms.<h4>Methods</h4>A systematic review of the recent English-language literature was conducted according to the European Association of Urology guidelines and the PRISMA statement recommendations (PROSPERO ID: CRD42021283136) using the MEDLINE, Cochrane Central Register of Controlled Trials, and ClinicalTrials.gov databases. Risk-of-bias assessment was performed according to the QUality In Prognosis Studies (QUIPS) tool.<h4>Results</h4>Overall, nine studies and one clinical trials were included. Eight studies reported results from RCC screening programs involving a total of 159 136 patients and "],"journal":["World journal of urology"],"pagination":["929-940"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10160199"],"repository":["biostudies-literature"],"pubmed_title":["Screening programs for renal cell carcinoma: a systematic review by the EAU young academic urologists renal cancer working group."],"pmcid":["PMC10160199"],"pubmed_authors":["Diana P","Klatte T","Marchioni M","Ingels A","Pavan N","Campi R","Carbonara U","Marandino L","Roussel E","Muselaers S","Amparore D","European Association of Urology (EAU) Young Academic Urologists (YAU) Renal Cancer group","Kara O","Erdem S","Bertolo R","Pecoraro A"],"additional_accession":[]},"is_claimable":false,"name":"Screening programs for renal cell carcinoma: a systematic review by the EAU young academic urologists renal cancer working group.","description":"<h4>Purpose</h4>To systematically review studies focused on screening programs for renal cell carcinoma (RCC) and provide an exhaustive overview on their clinical impact, potential benefits, and harms.<h4>Methods</h4>A systematic review of the recent English-language literature was conducted according to the European Association of Urology guidelines and the PRISMA statement recommendations (PROSPERO ID: CRD42021283136) using the MEDLINE, Cochrane Central Register of Controlled Trials, and ClinicalTrials.gov databases. Risk-of-bias assessment was performed according to the QUality In Prognosis Studies (QUIPS) tool.<h4>Results</h4>Overall, nine studies and one clinical trials were included. Eight studies reported results from RCC screening programs involving a total of 159 136 patients and ","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Apr","modification":"2026-05-02T11:15:00.378Z","creation":"2025-02-19T04:29:04.57Z"},"accession":"S-EPMC10160199","cross_references":{"pubmed":["35362747"],"doi":["10.1007/s00345-022-03993-6"]}}